ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | ESRRA |
ESR2
|
ENSG00000140009.14 | ESR2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESR2 | hg19_v2_chr14_-_64804814_64804842 | 0.62 | 9.9e-03 | Click! |
ESRRA | hg19_v2_chr11_+_64073699_64073918, hg19_v2_chr11_+_64073022_64073056 | 0.35 | 1.9e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_167369612 | 11.00 |
ENST00000507747.1 |
RP11-514O12.4 |
RP11-514O12.4 |
chr14_-_106174960 | 9.93 |
ENST00000390547.2 |
IGHA1 |
immunoglobulin heavy constant alpha 1 |
chr22_+_23248512 | 7.12 |
ENST00000390325.2 |
IGLC3 |
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr22_+_23243156 | 6.97 |
ENST00000390323.2 |
IGLC2 |
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr22_+_23237555 | 6.94 |
ENST00000390321.2 |
IGLC1 |
immunoglobulin lambda constant 1 (Mcg marker) |
chr9_-_116840728 | 6.88 |
ENST00000265132.3 |
AMBP |
alpha-1-microglobulin/bikunin precursor |
chr2_+_228678550 | 6.28 |
ENST00000409189.3 ENST00000358813.4 |
CCL20 |
chemokine (C-C motif) ligand 20 |
chr14_-_106054659 | 6.17 |
ENST00000390539.2 |
IGHA2 |
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr22_+_23241661 | 6.05 |
ENST00000390322.2 |
IGLJ2 |
immunoglobulin lambda joining 2 |
chr3_+_133465228 | 5.87 |
ENST00000482271.1 ENST00000264998.3 |
TF |
transferrin |
chr22_+_23247030 | 5.76 |
ENST00000390324.2 |
IGLJ3 |
immunoglobulin lambda joining 3 |
chr22_+_23264766 | 5.43 |
ENST00000390331.2 |
IGLC7 |
immunoglobulin lambda constant 7 |
chr1_-_173886491 | 5.30 |
ENST00000367698.3 |
SERPINC1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
chr19_+_35773242 | 5.29 |
ENST00000222304.3 |
HAMP |
hepcidin antimicrobial peptide |
chr17_-_7082861 | 5.24 |
ENST00000269299.3 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr14_-_106209368 | 5.10 |
ENST00000390548.2 ENST00000390549.2 ENST00000390542.2 |
IGHG1 |
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr3_-_50340996 | 4.88 |
ENST00000266031.4 ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1 |
hyaluronoglucosaminidase 1 |
chr12_+_112204691 | 4.67 |
ENST00000416293.3 ENST00000261733.2 |
ALDH2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
chr1_-_230850043 | 4.65 |
ENST00000366667.4 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr7_-_87104963 | 4.43 |
ENST00000359206.3 ENST00000358400.3 ENST00000265723.4 |
ABCB4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
chr12_-_117537240 | 4.37 |
ENST00000392545.4 ENST00000541210.1 ENST00000335209.7 |
TESC |
tescalcin |
chr12_+_57849048 | 4.22 |
ENST00000266646.2 |
INHBE |
inhibin, beta E |
chr6_+_31916733 | 4.21 |
ENST00000483004.1 |
CFB |
complement factor B |
chr10_+_7745303 | 4.20 |
ENST00000429820.1 ENST00000379587.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr10_-_54531406 | 4.11 |
ENST00000373968.3 |
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
chr18_+_29171689 | 4.06 |
ENST00000237014.3 |
TTR |
transthyretin |
chr2_-_238499303 | 4.02 |
ENST00000409576.1 |
RAB17 |
RAB17, member RAS oncogene family |
chr4_-_40517984 | 3.98 |
ENST00000381795.6 |
RBM47 |
RNA binding motif protein 47 |
chr14_-_106322288 | 3.98 |
ENST00000390559.2 |
IGHM |
immunoglobulin heavy constant mu |
chr10_+_7745232 | 3.92 |
ENST00000358415.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr22_+_23134974 | 3.90 |
ENST00000390314.2 |
IGLV2-11 |
immunoglobulin lambda variable 2-11 |
chr22_+_23229960 | 3.86 |
ENST00000526893.1 ENST00000532223.2 ENST00000531372.1 |
IGLL5 |
immunoglobulin lambda-like polypeptide 5 |
chr1_-_169555779 | 3.84 |
ENST00000367797.3 ENST00000367796.3 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
chr6_-_32498046 | 3.73 |
ENST00000374975.3 |
HLA-DRB5 |
major histocompatibility complex, class II, DR beta 5 |
chr22_+_23040274 | 3.68 |
ENST00000390306.2 |
IGLV2-23 |
immunoglobulin lambda variable 2-23 |
chr14_-_94856987 | 3.65 |
ENST00000449399.3 ENST00000404814.4 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr22_+_21128167 | 3.65 |
ENST00000215727.5 |
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr19_+_18284477 | 3.63 |
ENST00000407280.3 |
IFI30 |
interferon, gamma-inducible protein 30 |
chr16_+_23847339 | 3.62 |
ENST00000303531.7 |
PRKCB |
protein kinase C, beta |
chr1_-_24194771 | 3.62 |
ENST00000374479.3 |
FUCA1 |
fucosidase, alpha-L- 1, tissue |
chr11_+_116700600 | 3.61 |
ENST00000227667.3 |
APOC3 |
apolipoprotein C-III |
chr8_+_142402089 | 3.60 |
ENST00000521578.1 ENST00000520105.1 ENST00000523147.1 |
PTP4A3 |
protein tyrosine phosphatase type IVA, member 3 |
chr14_-_94857004 | 3.58 |
ENST00000557492.1 ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr17_+_27369918 | 3.47 |
ENST00000323372.4 |
PIPOX |
pipecolic acid oxidase |
chr6_+_33043703 | 3.45 |
ENST00000418931.2 ENST00000535465.1 |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
chr12_-_122296755 | 3.44 |
ENST00000289004.4 |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
chr19_+_50919056 | 3.44 |
ENST00000599632.1 |
CTD-2545M3.6 |
CTD-2545M3.6 |
chr17_-_7082668 | 3.43 |
ENST00000573083.1 ENST00000574388.1 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr19_+_45409011 | 3.41 |
ENST00000252486.4 ENST00000446996.1 ENST00000434152.1 |
APOE |
apolipoprotein E |
chr14_-_94856951 | 3.40 |
ENST00000553327.1 ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_-_111743285 | 3.40 |
ENST00000357640.4 |
DENND2D |
DENN/MADD domain containing 2D |
chr11_+_116700614 | 3.37 |
ENST00000375345.1 |
APOC3 |
apolipoprotein C-III |
chr16_-_88717423 | 3.36 |
ENST00000568278.1 ENST00000569359.1 ENST00000567174.1 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr19_+_42381173 | 3.31 |
ENST00000221972.3 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr6_+_13272904 | 3.31 |
ENST00000379335.3 ENST00000379329.1 |
PHACTR1 |
phosphatase and actin regulator 1 |
chr19_-_10450287 | 3.29 |
ENST00000589261.1 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr19_-_43032532 | 3.29 |
ENST00000403461.1 ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
chr17_-_64216748 | 3.28 |
ENST00000585162.1 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr14_-_55369525 | 3.23 |
ENST00000543643.2 ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1 |
GTP cyclohydrolase 1 |
chr3_+_52828805 | 3.21 |
ENST00000416872.2 ENST00000449956.2 |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
chr14_+_105953246 | 3.14 |
ENST00000392531.3 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
chrX_-_40036520 | 3.14 |
ENST00000406200.2 ENST00000378455.4 ENST00000342274.4 |
BCOR |
BCL6 corepressor |
chr11_-_116708302 | 3.11 |
ENST00000375320.1 ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1 |
apolipoprotein A-I |
chr14_+_105952648 | 3.09 |
ENST00000330233.7 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
chr4_+_100495864 | 3.09 |
ENST00000265517.5 ENST00000422897.2 |
MTTP |
microsomal triglyceride transfer protein |
chr4_-_155533787 | 3.05 |
ENST00000407946.1 ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG |
fibrinogen gamma chain |
chr10_-_52645379 | 3.04 |
ENST00000395489.2 |
A1CF |
APOBEC1 complementation factor |
chr6_+_6588316 | 3.00 |
ENST00000379953.2 |
LY86 |
lymphocyte antigen 86 |
chr19_-_39826639 | 2.97 |
ENST00000602185.1 ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG |
glia maturation factor, gamma |
chr13_-_46679185 | 2.95 |
ENST00000439329.3 |
CPB2 |
carboxypeptidase B2 (plasma) |
chr11_+_22696314 | 2.95 |
ENST00000532398.1 ENST00000433790.1 |
GAS2 |
growth arrest-specific 2 |
chr13_+_113760098 | 2.94 |
ENST00000346342.3 ENST00000541084.1 ENST00000375581.3 |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
chr11_-_67888881 | 2.92 |
ENST00000356135.5 |
CHKA |
choline kinase alpha |
chr13_-_46679144 | 2.91 |
ENST00000181383.4 |
CPB2 |
carboxypeptidase B2 (plasma) |
chr19_-_41256207 | 2.90 |
ENST00000598485.2 ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54 |
chromosome 19 open reading frame 54 |
chr19_+_35630926 | 2.88 |
ENST00000588081.1 ENST00000589121.1 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr20_+_56136136 | 2.88 |
ENST00000319441.4 ENST00000543666.1 |
PCK1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr11_+_46740730 | 2.85 |
ENST00000311907.5 ENST00000530231.1 ENST00000442468.1 |
F2 |
coagulation factor II (thrombin) |
chr16_+_3115298 | 2.85 |
ENST00000325568.5 ENST00000534507.1 |
IL32 |
interleukin 32 |
chr19_-_10450328 | 2.84 |
ENST00000160262.5 |
ICAM3 |
intercellular adhesion molecule 3 |
chr17_+_76164639 | 2.84 |
ENST00000225777.3 ENST00000585591.1 ENST00000589711.1 ENST00000588282.1 ENST00000589168.1 |
SYNGR2 |
synaptogyrin 2 |
chr12_+_6554021 | 2.80 |
ENST00000266557.3 |
CD27 |
CD27 molecule |
chr16_+_56995762 | 2.76 |
ENST00000200676.3 ENST00000379780.2 |
CETP |
cholesteryl ester transfer protein, plasma |
chr16_-_88717482 | 2.75 |
ENST00000261623.3 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr7_+_149571045 | 2.74 |
ENST00000479613.1 ENST00000606024.1 ENST00000464662.1 ENST00000425642.2 |
ATP6V0E2 |
ATPase, H+ transporting V0 subunit e2 |
chr19_-_6690723 | 2.72 |
ENST00000601008.1 |
C3 |
complement component 3 |
chr14_-_106237742 | 2.71 |
ENST00000390551.2 |
IGHG3 |
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr19_+_35630628 | 2.70 |
ENST00000588715.1 ENST00000588607.1 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr3_-_49722523 | 2.68 |
ENST00000448220.1 |
MST1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr2_-_21266935 | 2.66 |
ENST00000233242.1 |
APOB |
apolipoprotein B |
chr3_+_53880588 | 2.63 |
ENST00000288167.3 ENST00000494338.1 |
IL17RB |
interleukin 17 receptor B |
chr4_-_16077741 | 2.63 |
ENST00000447510.2 ENST00000540805.1 ENST00000539194.1 |
PROM1 |
prominin 1 |
chr17_-_76123101 | 2.62 |
ENST00000392467.3 |
TMC6 |
transmembrane channel-like 6 |
chr15_-_45670924 | 2.61 |
ENST00000396659.3 |
GATM |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr14_-_106330072 | 2.60 |
ENST00000488476.1 |
IGHJ5 |
immunoglobulin heavy joining 5 |
chr7_+_150065278 | 2.59 |
ENST00000519397.1 ENST00000479668.1 ENST00000540729.1 |
REPIN1 |
replication initiator 1 |
chr7_-_100239132 | 2.59 |
ENST00000223051.3 ENST00000431692.1 |
TFR2 |
transferrin receptor 2 |
chr20_+_61584026 | 2.57 |
ENST00000370351.4 ENST00000370349.3 |
SLC17A9 |
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
chr21_-_46330545 | 2.56 |
ENST00000320216.6 ENST00000397852.1 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr19_-_6720686 | 2.55 |
ENST00000245907.6 |
C3 |
complement component 3 |
chr16_+_85646763 | 2.55 |
ENST00000411612.1 ENST00000253458.7 |
GSE1 |
Gse1 coiled-coil protein |
chr19_+_45417812 | 2.54 |
ENST00000592535.1 |
APOC1 |
apolipoprotein C-I |
chr11_-_73687997 | 2.53 |
ENST00000545212.1 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
chr12_+_56477093 | 2.52 |
ENST00000549672.1 ENST00000415288.2 |
ERBB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr1_+_10271674 | 2.51 |
ENST00000377086.1 |
KIF1B |
kinesin family member 1B |
chr19_-_39108568 | 2.50 |
ENST00000586296.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr19_-_17516449 | 2.50 |
ENST00000252593.6 |
BST2 |
bone marrow stromal cell antigen 2 |
chr14_-_24911868 | 2.49 |
ENST00000554698.1 |
SDR39U1 |
short chain dehydrogenase/reductase family 39U, member 1 |
chr7_-_95025661 | 2.48 |
ENST00000542556.1 ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1 PON3 |
paraoxonase 1 paraoxonase 3 |
chrX_+_46940254 | 2.46 |
ENST00000336169.3 |
RGN |
regucalcin |
chr20_+_61287711 | 2.46 |
ENST00000370507.1 |
SLCO4A1 |
solute carrier organic anion transporter family, member 4A1 |
chr6_-_43027105 | 2.46 |
ENST00000230413.5 ENST00000487429.1 ENST00000489623.1 ENST00000468957.1 |
MRPL2 |
mitochondrial ribosomal protein L2 |
chr16_+_3115378 | 2.45 |
ENST00000529550.1 ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32 |
interleukin 32 |
chr6_-_2245892 | 2.44 |
ENST00000380815.4 |
GMDS |
GDP-mannose 4,6-dehydratase |
chr9_-_130966497 | 2.42 |
ENST00000393608.1 ENST00000372948.3 |
CIZ1 |
CDKN1A interacting zinc finger protein 1 |
chr10_-_52645416 | 2.42 |
ENST00000374001.2 ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF |
APOBEC1 complementation factor |
chr8_+_28174649 | 2.42 |
ENST00000301908.3 |
PNOC |
prepronociceptin |
chr14_+_95078714 | 2.41 |
ENST00000393078.3 ENST00000393080.4 ENST00000467132.1 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr16_+_85646891 | 2.41 |
ENST00000393243.1 |
GSE1 |
Gse1 coiled-coil protein |
chr17_-_66287350 | 2.37 |
ENST00000580666.1 ENST00000583477.1 |
SLC16A6 |
solute carrier family 16, member 6 |
chr11_+_7618413 | 2.37 |
ENST00000528883.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr6_+_13182751 | 2.37 |
ENST00000415087.1 |
PHACTR1 |
phosphatase and actin regulator 1 |
chr2_+_219646462 | 2.36 |
ENST00000258415.4 |
CYP27A1 |
cytochrome P450, family 27, subfamily A, polypeptide 1 |
chr16_-_21289627 | 2.34 |
ENST00000396023.2 ENST00000415987.2 |
CRYM |
crystallin, mu |
chrX_+_115567767 | 2.34 |
ENST00000371900.4 |
SLC6A14 |
solute carrier family 6 (amino acid transporter), member 14 |
chr5_-_149792295 | 2.34 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr17_-_7080801 | 2.34 |
ENST00000572879.1 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr10_+_114135952 | 2.32 |
ENST00000356116.1 ENST00000433418.1 ENST00000354273.4 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chrX_-_70331298 | 2.31 |
ENST00000456850.2 ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG |
interleukin 2 receptor, gamma |
chr19_+_1067492 | 2.30 |
ENST00000586866.1 |
HMHA1 |
histocompatibility (minor) HA-1 |
chr9_+_103947311 | 2.29 |
ENST00000395056.2 |
LPPR1 |
Lipid phosphate phosphatase-related protein type 1 |
chr1_+_145727681 | 2.29 |
ENST00000417171.1 ENST00000451928.2 |
PDZK1 |
PDZ domain containing 1 |
chr19_+_1440838 | 2.28 |
ENST00000594262.1 |
AC027307.3 |
Uncharacterized protein |
chr7_+_75609672 | 2.27 |
ENST00000545601.1 ENST00000450476.1 |
POR |
P450 (cytochrome) oxidoreductase |
chr19_+_52772821 | 2.24 |
ENST00000439461.1 |
ZNF766 |
zinc finger protein 766 |
chr16_+_3115323 | 2.22 |
ENST00000531965.1 ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32 |
interleukin 32 |
chr16_+_32077386 | 2.22 |
ENST00000354689.6 |
IGHV3OR16-9 |
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr6_-_41715128 | 2.21 |
ENST00000356667.4 ENST00000373025.3 ENST00000425343.2 |
PGC |
progastricsin (pepsinogen C) |
chr17_+_78075361 | 2.21 |
ENST00000577106.1 ENST00000390015.3 |
GAA |
glucosidase, alpha; acid |
chr22_+_24999114 | 2.19 |
ENST00000412658.1 ENST00000445029.1 ENST00000419133.1 ENST00000400382.1 ENST00000438643.2 ENST00000452551.1 ENST00000400383.1 ENST00000412898.1 ENST00000400380.1 ENST00000455483.1 ENST00000430289.1 |
GGT1 |
gamma-glutamyltransferase 1 |
chr11_+_22689648 | 2.19 |
ENST00000278187.3 |
GAS2 |
growth arrest-specific 2 |
chr12_-_103310987 | 2.17 |
ENST00000307000.2 |
PAH |
phenylalanine hydroxylase |
chr14_+_23016437 | 2.17 |
ENST00000478163.3 |
TRAC |
T cell receptor alpha constant |
chr12_+_7023735 | 2.16 |
ENST00000538763.1 ENST00000544774.1 ENST00000545045.2 |
ENO2 |
enolase 2 (gamma, neuronal) |
chr6_+_64346386 | 2.15 |
ENST00000509330.1 |
PHF3 |
PHD finger protein 3 |
chr11_-_2158507 | 2.13 |
ENST00000381392.1 ENST00000381395.1 ENST00000418738.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr22_-_47134077 | 2.13 |
ENST00000541677.1 ENST00000216264.8 |
CERK |
ceramide kinase |
chr19_+_35630022 | 2.13 |
ENST00000589209.1 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr2_-_20212422 | 2.13 |
ENST00000421259.2 ENST00000407540.3 |
MATN3 |
matrilin 3 |
chr3_-_58196939 | 2.09 |
ENST00000394549.2 ENST00000461914.3 |
DNASE1L3 |
deoxyribonuclease I-like 3 |
chr19_+_45449301 | 2.08 |
ENST00000591597.1 |
APOC2 |
apolipoprotein C-II |
chr16_+_85687999 | 2.06 |
ENST00000412692.1 |
GSE1 |
Gse1 coiled-coil protein |
chr16_+_28943260 | 2.05 |
ENST00000538922.1 ENST00000324662.3 ENST00000567541.1 |
CD19 |
CD19 molecule |
chr11_+_67033881 | 2.05 |
ENST00000308595.5 ENST00000526285.1 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
chr14_-_91884150 | 2.05 |
ENST00000553403.1 |
CCDC88C |
coiled-coil domain containing 88C |
chr14_-_24911448 | 2.04 |
ENST00000555355.1 ENST00000553343.1 ENST00000556523.1 ENST00000556249.1 ENST00000538105.2 ENST00000555225.1 |
SDR39U1 |
short chain dehydrogenase/reductase family 39U, member 1 |
chr2_+_128177458 | 2.04 |
ENST00000409048.1 ENST00000422777.3 |
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
chr22_-_22901636 | 2.04 |
ENST00000406503.1 ENST00000439106.1 ENST00000402697.1 ENST00000543184.1 ENST00000398743.2 |
PRAME |
preferentially expressed antigen in melanoma |
chr10_+_60145155 | 2.03 |
ENST00000373895.3 |
TFAM |
transcription factor A, mitochondrial |
chr17_-_38721711 | 2.03 |
ENST00000578085.1 ENST00000246657.2 |
CCR7 |
chemokine (C-C motif) receptor 7 |
chr16_+_3115611 | 2.03 |
ENST00000530890.1 ENST00000444393.3 ENST00000533097.2 ENST00000008180.9 ENST00000396890.2 ENST00000525228.1 ENST00000548652.1 ENST00000525377.2 ENST00000530538.2 ENST00000549213.1 ENST00000552936.1 ENST00000548476.1 ENST00000552664.1 ENST00000552356.1 ENST00000551513.1 ENST00000382213.3 ENST00000548246.1 |
IL32 |
interleukin 32 |
chr18_+_55816546 | 2.03 |
ENST00000435432.2 ENST00000357895.5 ENST00000586263.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr11_+_3876859 | 2.02 |
ENST00000300737.4 |
STIM1 |
stromal interaction molecule 1 |
chr1_-_27240455 | 2.02 |
ENST00000254227.3 |
NR0B2 |
nuclear receptor subfamily 0, group B, member 2 |
chr15_+_75335604 | 2.01 |
ENST00000563393.1 |
PPCDC |
phosphopantothenoylcysteine decarboxylase |
chr8_+_28196157 | 2.01 |
ENST00000522209.1 |
PNOC |
prepronociceptin |
chr19_-_4535233 | 2.01 |
ENST00000381848.3 ENST00000588887.1 ENST00000586133.1 |
PLIN5 |
perilipin 5 |
chr16_+_88869621 | 2.00 |
ENST00000301019.4 |
CDT1 |
chromatin licensing and DNA replication factor 1 |
chr6_+_31865552 | 2.00 |
ENST00000469372.1 ENST00000497706.1 |
C2 |
complement component 2 |
chr2_-_158300556 | 2.00 |
ENST00000264192.3 |
CYTIP |
cytohesin 1 interacting protein |
chr8_-_101348408 | 1.99 |
ENST00000519527.1 ENST00000522369.1 |
RNF19A |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr6_+_30130969 | 1.98 |
ENST00000376694.4 |
TRIM15 |
tripartite motif containing 15 |
chr16_-_67970990 | 1.97 |
ENST00000358514.4 |
PSMB10 |
proteasome (prosome, macropain) subunit, beta type, 10 |
chr11_-_73689037 | 1.96 |
ENST00000544615.1 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_-_238499131 | 1.95 |
ENST00000538644.1 |
RAB17 |
RAB17, member RAS oncogene family |
chr11_+_68080077 | 1.94 |
ENST00000294304.7 |
LRP5 |
low density lipoprotein receptor-related protein 5 |
chr19_-_10446449 | 1.94 |
ENST00000592439.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr4_+_140586922 | 1.94 |
ENST00000265498.1 ENST00000506797.1 |
MGST2 |
microsomal glutathione S-transferase 2 |
chr14_+_97059070 | 1.93 |
ENST00000553378.1 ENST00000555496.1 |
RP11-433J8.1 |
RP11-433J8.1 |
chr14_-_21492251 | 1.93 |
ENST00000554398.1 |
NDRG2 |
NDRG family member 2 |
chr19_-_51869592 | 1.93 |
ENST00000596253.1 ENST00000309244.4 |
ETFB |
electron-transfer-flavoprotein, beta polypeptide |
chr6_-_39693111 | 1.92 |
ENST00000373215.3 ENST00000538893.1 ENST00000287152.7 ENST00000373216.3 |
KIF6 |
kinesin family member 6 |
chr14_-_21492113 | 1.90 |
ENST00000554094.1 |
NDRG2 |
NDRG family member 2 |
chr6_+_32605134 | 1.89 |
ENST00000343139.5 ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
chr2_-_44065946 | 1.87 |
ENST00000260645.1 |
ABCG5 |
ATP-binding cassette, sub-family G (WHITE), member 5 |
chr16_+_56995854 | 1.87 |
ENST00000566128.1 |
CETP |
cholesteryl ester transfer protein, plasma |
chr22_-_37545972 | 1.87 |
ENST00000216223.5 |
IL2RB |
interleukin 2 receptor, beta |
chr16_+_222846 | 1.87 |
ENST00000251595.6 ENST00000397806.1 |
HBA2 |
hemoglobin, alpha 2 |
chr6_+_33172407 | 1.87 |
ENST00000374662.3 |
HSD17B8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
chr22_+_22550113 | 1.86 |
ENST00000390285.3 |
IGLV6-57 |
immunoglobulin lambda variable 6-57 |
chr16_+_30675654 | 1.86 |
ENST00000287468.5 ENST00000395073.2 |
FBRS |
fibrosin |
chr6_+_24403144 | 1.86 |
ENST00000274747.7 ENST00000543597.1 ENST00000535061.1 ENST00000378353.1 ENST00000378386.3 ENST00000443868.2 |
MRS2 |
MRS2 magnesium transporter |
chr19_-_4540486 | 1.86 |
ENST00000306390.6 |
LRG1 |
leucine-rich alpha-2-glycoprotein 1 |
chr17_+_4675175 | 1.85 |
ENST00000270560.3 |
TM4SF5 |
transmembrane 4 L six family member 5 |
chr2_-_88427568 | 1.85 |
ENST00000393750.3 ENST00000295834.3 |
FABP1 |
fatty acid binding protein 1, liver |
chr7_+_99971129 | 1.85 |
ENST00000394000.2 ENST00000350573.2 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
chr2_+_58655461 | 1.85 |
ENST00000429095.1 ENST00000429664.1 ENST00000452840.1 |
AC007092.1 |
long intergenic non-protein coding RNA 1122 |
chr17_+_19437132 | 1.85 |
ENST00000436810.2 ENST00000270570.4 ENST00000457293.1 ENST00000542886.1 ENST00000575023.1 ENST00000395585.1 |
SLC47A1 |
solute carrier family 47 (multidrug and toxin extrusion), member 1 |
chr14_-_106406090 | 1.84 |
ENST00000390593.2 |
IGHV6-1 |
immunoglobulin heavy variable 6-1 |
chr12_+_7023491 | 1.84 |
ENST00000541477.1 ENST00000229277.1 |
ENO2 |
enolase 2 (gamma, neuronal) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:1903413 | cellular response to bile acid(GO:1903413) |
2.9 | 11.7 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
2.5 | 9.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.1 | 6.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.9 | 5.8 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.8 | 3.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.8 | 5.4 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
1.8 | 8.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.8 | 5.3 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
1.7 | 5.2 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
1.7 | 5.0 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
1.7 | 5.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.7 | 16.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.7 | 10.0 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
1.6 | 9.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.6 | 8.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.6 | 4.8 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
1.5 | 4.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
1.5 | 4.4 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
1.4 | 8.6 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.3 | 2.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.3 | 3.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.2 | 3.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.2 | 6.1 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.2 | 9.5 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
1.1 | 4.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.1 | 1.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
1.1 | 3.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
1.1 | 3.3 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
1.1 | 3.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
1.1 | 4.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.0 | 3.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
1.0 | 3.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.0 | 5.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.0 | 1.0 | GO:0048545 | response to steroid hormone(GO:0048545) |
1.0 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.0 | 1.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.0 | 2.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.9 | 2.8 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.9 | 2.8 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.9 | 3.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.9 | 3.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.9 | 2.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.9 | 11.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 4.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 3.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 4.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.8 | 2.5 | GO:1904647 | response to rotenone(GO:1904647) |
0.8 | 5.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 4.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.8 | 5.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.8 | 7.2 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.8 | 4.8 | GO:0030421 | defecation(GO:0030421) |
0.8 | 2.3 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.8 | 3.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.8 | 2.3 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.7 | 2.2 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.7 | 1.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.7 | 50.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.7 | 1.4 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.7 | 1.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.7 | 0.7 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.7 | 2.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.7 | 3.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.7 | 2.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.7 | 3.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 3.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 3.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.7 | 6.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.7 | 6.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.7 | 5.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.6 | 4.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.6 | 0.6 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.6 | 2.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 9.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.6 | 2.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.6 | 3.8 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.6 | 2.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.6 | 6.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 0.6 | GO:0015942 | formate metabolic process(GO:0015942) |
0.6 | 2.5 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.6 | 3.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.6 | 1.8 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.6 | 3.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.6 | 1.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.6 | 4.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.6 | 3.0 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.6 | 7.1 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.6 | 1.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.6 | 2.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.6 | 1.8 | GO:0003285 | septum secundum development(GO:0003285) |
0.6 | 5.8 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 1.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.6 | 1.7 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.6 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.6 | 0.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 1.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.5 | 1.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 8.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 1.6 | GO:1902997 | protein retention in Golgi apparatus(GO:0045053) regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 1.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.5 | 1.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.5 | 1.6 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.5 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.5 | 2.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 3.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 1.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.5 | 5.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 1.0 | GO:2000667 | positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 0.5 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.5 | 1.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.5 | 7.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 1.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.5 | 0.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 0.5 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.5 | 2.4 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.5 | 1.4 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.5 | 1.4 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.5 | 1.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.5 | 1.8 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.4 | 2.7 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 4.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 2.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.3 | GO:1902499 | regulation of protein autoubiquitination(GO:1902498) positive regulation of protein autoubiquitination(GO:1902499) |
0.4 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.4 | 2.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.4 | 3.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.4 | 0.4 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.4 | 1.3 | GO:0038185 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.4 | 3.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 3.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 4.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 0.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 | 4.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.4 | 0.4 | GO:0031548 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.4 | 0.8 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.4 | 1.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.4 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 1.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.4 | 2.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 1.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 0.8 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.4 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 1.2 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.4 | 1.9 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.4 | 1.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.4 | 1.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.4 | 3.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 1.1 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.4 | 1.1 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 3.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 3.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 7.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 0.7 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.4 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.4 | 5.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 0.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.4 | 4.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 0.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.4 | 1.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.4 | 1.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.4 | 1.1 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.4 | 1.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.4 | 4.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 1.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.3 | 0.3 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.3 | 2.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 2.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.3 | 2.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 1.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 1.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.3 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 0.7 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.3 | 3.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 4.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 4.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.3 | 1.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.3 | 1.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 2.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 2.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.3 | 1.6 | GO:0033031 | regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 1.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 1.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.3 | GO:0061718 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.3 | 0.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 1.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.3 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.9 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 1.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.3 | 1.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 2.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 0.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 1.2 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.3 | 0.9 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.3 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 3.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 4.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 0.3 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 1.8 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 0.6 | GO:0060920 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.3 | 0.9 | GO:1904044 | response to aldosterone(GO:1904044) |
0.3 | 0.6 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.3 | 0.9 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 3.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 3.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 0.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.3 | 0.9 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.3 | 1.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.3 | 1.2 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.3 | 0.9 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.3 | 1.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 3.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 2.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.3 | 0.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.3 | 1.2 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.3 | 3.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.9 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.3 | 0.9 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.3 | 1.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 6.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 1.1 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
0.3 | 1.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 0.6 | GO:0043144 | snoRNA processing(GO:0043144) |
0.3 | 1.1 | GO:1904448 | gamma-aminobutyric acid biosynthetic process(GO:0009449) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.3 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.3 | 23.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 1.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 5.5 | GO:0006067 | ethanol metabolic process(GO:0006067) |
0.3 | 0.5 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.3 | 0.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.3 | 0.3 | GO:2000360 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.3 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
0.3 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.3 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 2.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 0.8 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 1.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 3.4 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 2.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.5 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.3 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 1.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 15.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.8 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.3 | 1.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 2.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 1.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.2 | 0.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.2 | 0.7 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.5 | GO:1903412 | response to bile acid(GO:1903412) |
0.2 | 0.2 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.2 | 0.5 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.2 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 2.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 1.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.2 | 1.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.2 | 2.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 1.7 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.2 | 0.2 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.2 | 1.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 2.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.2 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.4 | GO:2000491 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.7 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.2 | 1.0 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.2 | 1.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.2 | 9.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.2 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.7 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.2 | 1.2 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.2 | 0.9 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 5.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.5 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.2 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 21.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 3.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 2.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 4.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 2.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.5 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.2 | 1.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.2 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.9 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 0.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.7 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 3.6 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.2 | 0.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 2.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.7 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 | 1.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.7 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 1.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 1.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.7 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.2 | 0.4 | GO:0046016 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.6 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 0.9 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.2 | 0.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.2 | 0.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 0.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 0.2 | GO:0043092 | L-amino acid import(GO:0043092) |
0.2 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 5.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.2 | 0.6 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.2 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 2.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 2.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.2 | 1.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 0.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.2 | 3.9 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 1.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.2 | 0.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.2 | 1.4 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.8 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 1.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 1.0 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 0.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 2.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 0.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.4 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 0.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 2.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.2 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 0.8 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.2 | 0.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.6 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.2 | 1.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 1.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 1.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 10.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 4.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.4 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 2.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 0.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.2 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 1.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 1.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 2.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 1.3 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.2 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 4.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 3.0 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 1.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) female courtship behavior(GO:0008050) |
0.2 | 1.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 1.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.3 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.2 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 2.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.2 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 0.7 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.7 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.8 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.2 | 2.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 1.3 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 1.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 1.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.8 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.2 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.7 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.2 | 0.5 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.2 | 1.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.3 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.2 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.5 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.2 | 1.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 3.0 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.8 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.2 | 0.8 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.2 | 1.6 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 2.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.3 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.3 | GO:1902728 | positive regulation of skeletal muscle cell proliferation(GO:0014858) mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.2 | 1.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.2 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.2 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 4.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
0.2 | 0.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 0.5 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 0.2 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.2 | 0.6 | GO:0090625 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.2 | 0.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.2 | GO:0086065 | cell communication involved in cardiac conduction(GO:0086065) |
0.2 | 0.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 2.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.8 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.2 | 1.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.1 | 0.6 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.6 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.1 | 0.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 10.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 2.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.9 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.1 | 0.4 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.1 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 2.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 1.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.4 | GO:2000683 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) oncogene-induced cell senescence(GO:0090402) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) regulation of cellular response to drug(GO:2001038) |
0.1 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 1.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.6 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 1.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.4 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 5.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0045117 | azole transport(GO:0045117) |
0.1 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 2.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 1.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 2.3 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.7 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 1.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0033008 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.4 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.6 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.4 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 1.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 0.6 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 1.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.2 | GO:0048521 | negative regulation of behavior(GO:0048521) negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.4 | GO:0072278 | comma-shaped body morphogenesis(GO:0072049) metanephric comma-shaped body morphogenesis(GO:0072278) |
0.1 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.2 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 1.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.1 | 3.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.4 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.5 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
0.1 | 0.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 6.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 3.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 3.7 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 1.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.5 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.6 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.1 | 1.6 | GO:2000615 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 1.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.1 | GO:0045765 | regulation of angiogenesis(GO:0045765) regulation of vasculature development(GO:1901342) |
0.1 | 0.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 1.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 5.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 1.4 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.1 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 1.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.6 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.1 | 0.3 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 3.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0031622 | positive regulation of fever generation(GO:0031622) positive regulation of heat generation(GO:0031652) |
0.1 | 1.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 1.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 6.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.2 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 1.4 | GO:0044818 | mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.1 | GO:0014857 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 2.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 7.1 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 1.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.6 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0051583 | synaptic transmission, dopaminergic(GO:0001963) dopamine transport(GO:0015872) dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.2 | GO:0006272 | leading strand elongation(GO:0006272) |
0.1 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.2 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 1.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.3 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 1.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 1.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.7 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.4 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.7 | GO:0046189 | phenol-containing compound biosynthetic process(GO:0046189) |
0.1 | 0.3 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.6 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.4 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.9 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 0.3 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.3 | GO:1901355 | response to rapamycin(GO:1901355) |
0.1 | 0.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.1 | 0.5 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.2 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.7 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 0.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 1.2 | GO:0021762 | substantia nigra development(GO:0021762) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 2.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 1.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.5 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.2 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 2.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 1.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.7 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 1.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.5 | GO:0000732 | strand displacement(GO:0000732) |
0.1 | 1.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.1 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.0 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.1 | 0.2 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 1.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 4.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 1.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.1 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 0.5 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.3 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.7 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) neurotrophin production(GO:0032898) regulation of neurotrophin production(GO:0032899) negative regulation of neurotrophin production(GO:0032900) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0048469 | cell maturation(GO:0048469) |
0.1 | 0.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.1 | GO:0046602 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) centrosome separation(GO:0051299) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 1.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.7 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.5 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.1 | 0.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.2 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.6 | GO:1904851 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.0 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.1 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 1.3 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 1.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 1.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 2.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 4.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.0 | 0.3 | GO:0043217 | myelin maintenance(GO:0043217) |
0.0 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.0 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.0 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 2.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.2 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.4 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.4 | GO:0090659 | walking behavior(GO:0090659) |
0.0 | 1.8 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.2 | GO:0045144 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) |
0.0 | 0.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 5.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 1.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.2 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.0 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.4 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 1.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.0 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.2 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.0 | 0.7 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.4 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0051354 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.2 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 1.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.2 | GO:0051985 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.0 | 1.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.0 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0070781 | response to biotin(GO:0070781) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:0070988 | demethylation(GO:0070988) |
0.0 | 0.0 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.0 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.4 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.0 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.0 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 1.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.0 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.0 | 0.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.0 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.0 | GO:2001182 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.0 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 1.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 14.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 1.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 2.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 32.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 8.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 23.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 9.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 12.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 10.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 8.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 6.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 9.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 15.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 3.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 14.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 3.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 9.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 6.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 7.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 7.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 5.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 6.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 11.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 4.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 7.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 6.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 5.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 4.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 4.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.3 | 6.8 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
2.2 | 6.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
2.1 | 10.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.0 | 7.9 | GO:0019862 | IgA binding(GO:0019862) |
1.9 | 3.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.8 | 14.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.6 | 4.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.6 | 4.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.6 | 4.7 | GO:0017129 | triglyceride binding(GO:0017129) |
1.5 | 4.4 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.4 | 5.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.4 | 8.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.3 | 4.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.2 | 3.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.2 | 3.6 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
1.2 | 66.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.2 | 5.9 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
1.1 | 4.4 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 3.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.0 | 3.0 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.0 | 3.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 3.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 3.9 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.8 | 3.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.7 | 2.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.7 | 2.2 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.7 | 2.2 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.7 | 4.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.7 | 5.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.7 | 2.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.7 | 4.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.7 | 2.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 2.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.7 | 3.3 | GO:0070404 | NADH binding(GO:0070404) |
0.7 | 2.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 9.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.6 | 4.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 2.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 1.8 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.6 | 1.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.6 | 3.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 4.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.6 | 2.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 4.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 2.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.6 | 2.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.6 | 5.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.6 | 2.8 | GO:0070905 | serine binding(GO:0070905) |
0.6 | 7.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.6 | 2.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 3.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 9.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 1.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 4.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 1.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 3.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 1.6 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.5 | 1.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.5 | 2.6 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.5 | 1.6 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.5 | 1.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 4.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 13.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.5 | 1.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.5 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 10.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 3.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 1.9 | GO:0004803 | transposase activity(GO:0004803) |
0.5 | 1.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 1.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.5 | 4.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 3.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 4.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 2.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 3.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 0.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.4 | 1.3 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.4 | 3.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.4 | 2.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 7.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 1.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.4 | 1.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.4 | 1.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 2.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 2.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 2.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.4 | 1.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 6.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 1.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.4 | 1.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.4 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 2.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 6.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 6.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 0.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.3 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.4 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 1.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.3 | 2.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 1.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 9.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 2.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 3.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 3.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.0 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.3 | 2.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 1.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.0 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.3 | 1.0 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.3 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.0 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.3 | 5.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.3 | 1.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 0.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.3 | 1.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.3 | 0.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 1.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 0.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 1.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.3 | 1.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 0.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 2.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 2.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 4.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 5.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.3 | 1.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 1.1 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 3.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 4.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 1.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.3 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.3 | 5.4 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 0.3 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.3 | 1.5 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.2 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.7 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 1.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 8.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.2 | 1.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.7 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.2 | 2.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 1.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.2 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 2.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 30.9 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 2.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 2.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 4.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.9 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.2 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.2 | 0.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.2 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 2.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.5 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.8 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.2 | 1.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 9.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 0.8 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 0.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.2 | 7.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 4.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.2 | 0.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 1.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 4.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.5 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 0.5 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.2 | 1.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 1.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 2.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 5.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.5 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.2 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 3.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 2.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 2.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 2.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 0.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.2 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 17.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.5 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.2 | 0.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.8 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.2 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 0.5 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.2 | 0.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 0.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 2.4 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.2 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 2.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 1.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.3 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 1.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 2.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 15.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 6.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.8 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 5.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 2.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 4.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 2.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.1 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 1.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.4 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 1.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.8 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 2.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 5.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 2.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 5.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 7.9 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 8.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.1 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.6 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 1.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 2.7 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 4.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.9 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 2.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 1.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 0.3 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.1 | 4.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 2.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 5.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 15.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.6 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 0.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 5.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.1 | 1.7 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.3 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.1 | GO:0001016 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 0.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 1.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) |
0.1 | 2.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 2.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 2.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 1.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.3 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.1 | 0.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 3.1 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.0 | 1.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 1.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 3.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 1.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 3.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.5 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.2 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 31.3 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.0 | 0.6 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.2 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 1.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 1.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 1.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 3.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 2.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 24.0 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 3.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.8 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.0 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.0 | GO:0022853 | active ion transmembrane transporter activity(GO:0022853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.4 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
2.7 | 21.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.8 | 5.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.2 | 9.5 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 49.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.0 | 21.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.0 | 3.1 | GO:0097183 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
1.0 | 6.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 13.5 | GO:0042627 | chylomicron(GO:0042627) |
0.8 | 2.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.8 | 5.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.8 | 5.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.8 | 9.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.7 | 4.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 4.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.7 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 10.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 11.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 3.3 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
0.5 | 2.6 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.5 | 2.1 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 2.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 3.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 6.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.5 | 3.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 3.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 1.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 4.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 2.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 5.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 0.8 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.4 | 3.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 2.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 9.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 2.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 2.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 4.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.0 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.3 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 5.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 0.9 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.3 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.9 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.3 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 4.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 45.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 2.0 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 1.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.3 | 1.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 1.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.3 | 0.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 4.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 13.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.9 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.2 | 3.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.3 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.0 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.2 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 1.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 8.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 0.4 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 4.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 0.6 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 3.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 7.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 2.5 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.7 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 1.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 2.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 2.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 0.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.5 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.0 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 9.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 1.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 0.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 2.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 3.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.3 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 7.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.4 | GO:0005715 | late recombination nodule(GO:0005715) |
0.1 | 0.9 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 10.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 3.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.3 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 8.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 9.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 7.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 1.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 6.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.8 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.2 | GO:0000803 | sex chromosome(GO:0000803) X chromosome(GO:0000805) Barr body(GO:0001740) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 1.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.2 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 4.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 27.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.1 | 2.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 6.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.3 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 5.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 3.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 4.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 2.4 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 2.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 2.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 3.0 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 9.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 13.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.7 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 4.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 4.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.0 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 2.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 2.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0033647 | host intracellular part(GO:0033646) host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) host cell nucleus(GO:0042025) intracellular region of host(GO:0043656) host cell nuclear part(GO:0044094) |
0.0 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) cell tip(GO:0051286) |
0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 5.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 5.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 1.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.0 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 2.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 1.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:1990031 | pinceau fiber(GO:1990031) |
0.0 | 1.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.3 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 1.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.3 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.0 | 0.0 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 1.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0097228 | sperm principal piece(GO:0097228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 27.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 19.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.2 | 6.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.9 | 20.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 6.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 16.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.6 | 5.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 5.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 5.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 3.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 3.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 5.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 5.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 5.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 9.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 5.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 5.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 0.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 5.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 5.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 8.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 3.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 6.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 4.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 13.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 16.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 2.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.3 | 5.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 7.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 5.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 18.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 5.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 3.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 6.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 10.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 4.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 6.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 1.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 5.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 6.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 9.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 3.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 3.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 3.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 3.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 10.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 2.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 9.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 6.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 13.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 4.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 4.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.5 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 3.7 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 3.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 12.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 7.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 6.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.9 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.3 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.0 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |